Insilico Medicine to present three abstracts at the 2026 Crohn’s & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411, a novel gut-restricted PHD1/2 inhibitor for inflammatory bowel disease - EurekAlert!
INFORMS names six finalists for the 2026 Franz Edelman Award, the world’s leading honor in analytics, operations research and management science - EurekAlert!
